Maxim Egorov

745 total citations
16 papers, 313 citations indexed

About

Maxim Egorov is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maxim Egorov has authored 16 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Epidemiology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maxim Egorov's work include ATP Synthase and ATPases Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Maxim Egorov is often cited by papers focused on ATP Synthase and ATPases Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Maxim Egorov collaborates with scholars based in Russia, Sweden and Tajikistan. Maxim Egorov's co-authors include M. I. Shakhparonov, Vladimir P. Skulachev, Jan Rydström, Maxim V. Skulachev, Irina G. Shabalina, M. Yu. Vyssokikh, В. А. Выгодин, Konstantin G. Lyamzaev, Roman A. Zinovkin and Vasily N. Manskikh and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and Scientific Reports.

In The Last Decade

Maxim Egorov

15 papers receiving 308 citations

Peers

Countries citing papers authored by Maxim Egorov

Since Specialization

Citations

This map shows the geographic impact of Maxim Egorov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Egorov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Egorov more than expected).

Fields of papers citing papers by Maxim Egorov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Egorov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Egorov. The network helps show where Maxim Egorov may publish in the future.

Co-authorship network of co-authors of Maxim Egorov

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Egorov. A scholar is included among the top collaborators of Maxim Egorov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Egorov. Maxim Egorov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Mitochondrion-targeted antioxidant SkQ1 prevents rapid animal death caused by highly diverse shocks 2023 ·Scientific Reports ·Vladimir P. Skulachev, M. Yu. Vyssokikh, Boris V. Chernyak, О. А. Аверина, Alexander Andreev‐Andrievskiy, Roman A. Zinovkin, Konstantin G. Lyamzaev, Maria V. Marey, Maxim Egorov, (unknown), Dmitry B. Zorov, Maxim V. Skulachev, В. А. Садовничий	16
2	Magnetic Resonance Spectroscopy in the Diagnosis and Prognosis of Breast Cancer 2019 ·SHILAP Revista de lepidopterología ·Maxim Egorov, В. Е. Синицын, (unknown)	0
3	Comparison of the Effects of Mitochondria-Targeted Antioxidant 10-(6’-Plastoquinonyl)Decyltriphenylphosphonium Bromide (SkQ1) and a Fragment of its Molecule Dodecyltriphenylphosphonium on Carrageenan-Induced Acute Inflammation in Mouse Model of Subcuteneous Air Pouch 2017 ·Bulletin of Experimental Biology and Medicine ·M. A. Chelombitko, О. А. Аверина, (unknown), (unknown), Maxim Egorov, Olga Yu. Pletjushkina, E. N. Popova, (unknown), (unknown), O.P. Ilyinskaya	8
4	Effect of SkQ1 Antioxidant on Structural and Functional Conditions of The Brain in PostResuscitation Period 2016 ·General Reanimatology ·(unknown), (unknown), О. А. Аверина, (unknown), (unknown), (unknown), В. В. Мороз, Maxim Egorov	1
5	Efficacy of Mitochondrial Antioxidant Plastoquinonyl‐decyl‐triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis 2016 ·Oxidative Medicine and Cellular Longevity ·Alexander Andreev‐Andrievskiy, Н. Г. Колосова, Natalia A. Stefanova, (unknown), Maxim Egorov, Vasily N. Manskikh, Roman A. Zinovkin, Ivan I. Galkin, Anastasia S. Prikhodko, Maxim V. Skulachev, Alexander N. Lukashev	21
6	Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1. 2015 ·PubMed ·(unknown), Olga Gancharova, (unknown), (unknown), Irina G. Shabalina, Maxim Egorov, (unknown), (unknown), Ivan I. Galkin, Vladimir P. Skulachev, Roman A. Zinovkin	27
7	Effect of the mitochondria-targeted antioxidant SkQ1 on development of spontaneous tumors in BALB/c mice 2014 ·Biochemistry (Moscow) ·(unknown), (unknown), В. А. Выгодин, Maxim Egorov	7
8	Systems Biology of Free Radicals and Antioxidants 2014 ·Roman A. Zinovkin, L. E. Bakeeva, Boris V. Chernyak, Maxim Egorov, Н. К. Исаев, (unknown), Galina A. Korshunova, (unknown), М. П. Мошкин, Egor Y. Plotnikov, Konstantin A. Rogovin, (unknown), Andrey A. Zamyatnin, Dmitry B. Zorov, Maxim V. Skulachev, Vladimir P. Skulachev	15
9	Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents 2011 ·Aging ·Vladimir N. Anisimov, Maxim Egorov, (unknown), Konstantin G. Lyamzaev, Vasily N. Manskikh, М. П. Мошкин, Е. А. Новиков, Irina G. Popovich, Konstantin A. Rogovin, Irina G. Shabalina, (unknown), Maxim V. Skulachev, (unknown), В. А. Выгодин, M. Yu. Vyssokikh, M. N. Yurova, (unknown), Vladimir P. Skulachev	95
10	Novel mitochondria-targeted antioxidants, “Skulachev-Ion” derivatives, accelerate dermal wound healing in animals 2010 ·Biochemistry (Moscow) ·(unknown), (unknown), L. V. Domnina, Vera B. Dugina, Maxim Egorov, O. Yu. Ivanova, (unknown), Olga Yu. Pletjushkina, E. N. Popova, Ivan Yu. Sakharov, (unknown), Boris V. Chernyak	29
11	Purification of a recombinant membrane protein tagged with a calmodulin-binding domain: properties of chimeras of the Escherichia coli nicotinamide nucleotide transhydrogenase and the C-terminus of human plasma membrane Ca2+-ATPase 2004 ·Protein Expression and Purification ·Maxim Egorov, (unknown), Nikolay B. Pestov, Tatyana V. Korneenko, (unknown), M. I. Shakhparonov, Jan Rydström	10
12	Expression of proton-pumping nicotinamide nucleotide transhydrogenase in mouse, human brain and C. elegans 2002 ·Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology ·Eva Lagberg Arkblad, Maxim Egorov, M. I. Shakhparonov, (unknown), (unknown), Jan Rydström	38
13	Interactions between the soluble domain I of nicotinamide nucleotide transhydrogenase from Rhodospirillum rubrum and transhydrogenase from Escherichia coli 2000 ·European Journal of Biochemistry ·Tania Bizouarn, Ola Fjellström, Magnus Axelsson, Tatyana V. Korneenko, Nikolay B. Pestov, (unknown), Maxim Egorov, M. I. Shakhparonov, Jan Rydström	10
14	The identification of nitrate reductase fromEscherichia coli as the antigen for a monoclonal antibody of unknown specificity 2000 ·Russian Journal of Bioorganic Chemistry ·Tatyana V. Korneenko, Nikolay B. Pestov, Maxim Egorov, (unknown), М. Б. Костина, Jan Rydström, M. I. Shakhparonov	1
15	Ouabain‐sensitive H,K‐ATPase: tissue‐specific expression of the mammalian genes encoding the catalytic α subunit¹ 1998 ·FEBS Letters ·Nikolay B. Pestov, (unknown), Tatyana V. Korneenko, Maxim Egorov, (unknown), (unknown), Amir Askari, M. I. Shakhparonov, Nikolaï N. Modyanov	34
16	Course and Treatment of Obesity 1959 ·American Journal of Clinical Nutrition ·Maxim Egorov, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact